<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-6CI84BGM</identifier><date>2017</date><creator>Horvat, Alenka</creator><relation>documents/doc/6/URN_NBN_SI_doc-6CI84BGM_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-6CI84BGM_001.txt</relation><format format_type="issue">4</format><format format_type="volume">68</format><format format_type="type">article</format><format format_type="extent">str. 288-291</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">30981927</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-6CI84BGM</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><title>New treatments of multiple sclerosis</title><title>Novosti v zdravljenju multiple skleroze</title></Record>